CERA

unofficial impact factor 1.46

Download references

Open Access

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration

Susan F Hurley*, Jane P Matthews and Robyn H Guymer

Cost Effectiveness and Resource Allocation 2008, 6:12 doi:10.1186/1478-7547-6-12

Include


Format